Intellectual Property Rights and Innovation: Evidence from the Human Genome
Top Cited Papers
Open Access
- 1 February 2013
- journal article
- Published by University of Chicago Press in Journal of Political Economy
- Vol. 121 (1), 1-27
- https://doi.org/10.1086/669706
Abstract
Do intellectual property (IP) rights on existing technologies hinder subsequent innovation? Using newly-collected data on the sequencing of the human genome by the public Human Genome Project and the private rm Celera, this paper estimates the impact of Celera's gene-level IP on subsequent scienti c research and product development. Genes initially sequenced by Celera were held with IP for up to two years, but moved into the public domain once re-sequenced by the public e ort. Across a range of empirical speci cations, I nd evidence that Celera's IP led to reductions in subsequent scienti c research and product development on the order of 20 to 30 percent. Taken together, these results suggest that Celera's short-term IP had persistent negative e ects on subsequent innovation relative to a counterfactual of Celera genes having always been in the public domainKeywords
This publication has 32 references indexed in Scilit:
- How does the management of research impact the disclosure of knowledge? Evidence from scientific publications and patenting behaviorEconomics of Innovation and New Technology, 2011
- Defining Genes in the Genomics EraScience, 2003
- Can Data Banks Tally Profits?Science, 2001
- Initial sequencing and analysis of the human genomeNature, 2001
- Incumbency And R&D Incentives: Licensing The Gale Of Creative DestructionJournal of Economics & Management Strategy, 2000
- Genomics in the public domain: strategy and policyNature Reviews Genetics, 2000
- Academic Sequencers Challenge Celera in a Sprint to the FinishScience, 1999
- NIH to Produce a 'Working Draft' of the Genome by 2001Science, 1998
- Shotgun Sequencing of the Human GenomeScience, 1998
- On the Complex Economics of Patent ScopeColumbia Law Review, 1990